NWI Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

NWI Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50,000	Closed	-$6.95M	–	57
2021 Q3	$6.95M	Hold	50,000	–	–	0.43%	34
2021 Q2	$4.85M	Hold	50,000	–	–	0.3%	38
2021 Q1	$3.42M	Hold	50,000	–	–	0.28%	37
2020 Q4	$4.29M	Sell	50,000 -95,000	-66%	-$8.05M	0.43%	32
2020 Q3	$9.43M	Sell	145,000 -255,000	-64%	-$16.7M	0.82%	21
2020 Q2	$29.2M	Hold	400,000	–	–	2.32%	11
2020 Q1	$13.6M	Buy	400,000 +200,000	+100%	+$9.14M	1.15%	18
2019 Q4	$10.9M	Hold	200,000	–	–	0.45%	28
2019 Q3	$8.34M	Buy	+200,000	New	+$8.45M	0.52%	26

Other funds holding BHVN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NWI Management's BHVN Position: Q4 2021 in Review

NWI Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2021, closing a stake of 50,000 shares — an estimated $6.95M sold.

NWI Management first reported a position in BHVN in Q3 2019 and held it in 9 quarters. The position peaked at $29.2M in Q2 2020. 284 funds tracked by Wall St. Rank hold BHVN as of Q4 2021.

NWI Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2021 after selling out during the quarter.
NWI Management sold 50,000 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2021, an estimated $6.95M.
NWI Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019 and held it in 9 quarters.
NWI Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $29.2M in Q2 2020.
284 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2021.

Based on NWI Management's 13F filing for Q4 2021, filed 14 Feb 2022.